These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12969171)

  • 1. Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure.
    Prinsen BH; Rabelink TJ; Beutler JJ; Kaysen GA; De Boer J; Boer WH; Hagen EC; Berger R; De Sain-Van Der Velden MG
    Kidney Int; 2003 Oct; 64(4):1495-504. PubMed ID: 12969171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: measurements with stable isotopes.
    de Sain-van der Velden MG; Kaysen GA; de Meer K; Stellaard F; Voorbij HA; Reijngoud DJ; Rabelink TJ; Koomans HA
    Kidney Int; 1998 Jan; 53(1):181-8. PubMed ID: 9453016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysate vascular endothelial growth factor is an independent determinant of serum albumin levels and predicts future withdrawal from peritoneal dialysis in uremic patients.
    Hazama T; Fukami K; Yamagishi S; Kusumoto T; Sakai K; Adachi T; Sonoda K; Kasuga S; Ueda S; Okuda S
    Ther Apher Dial; 2014 Oct; 18(5):391-7. PubMed ID: 24251735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients.
    Heaf JG; Sarac S; Afzal S
    Nephrol Dial Transplant; 2005 Oct; 20(10):2194-201. PubMed ID: 16030031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria.
    Tessari P; Kiwanuka E; Millioni R; Vettore M; Puricelli L; Zanetti M; Gucciardi A; Tosolini M; Cogo P; Carnielli V; Tiengo A; Barazzoni R
    Diabetes Care; 2006 Feb; 29(2):323-8. PubMed ID: 16443881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory factors for hypoalbuminemia in Japanese peritoneal dialysis patients.
    Shioya M; Yoshida T; Kasai K; Furuya R; Kato A; Mori N; Matsumoto Y; Kumagai H
    Nephrology (Carlton); 2013 Aug; 18(8):539-44. PubMed ID: 23718260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen levels in hemodialysis patients.
    Kaysen GA; Dubin JA; Müller HG; Mitch WE; Rosales L; Levin NW;
    Kidney Int; 2003 Jan; 63(1):315-22. PubMed ID: 12472798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes.
    Tessari P; Kiwanuka E; Barazzoni R; Vettore M; Zanetti M
    Diabetologia; 2006 Aug; 49(8):1955-61. PubMed ID: 16703327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin synthesis, catabolism and distribution in dialysis patients.
    Kaysen GA; Yeun J; Depner T
    Miner Electrolyte Metab; 1997; 23(3-6):218-24. PubMed ID: 9387121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypoalbuminemia in dialysis. Is it a marker for malnutrition or inflammation?].
    Cueto Manzano AM
    Rev Invest Clin; 2001; 53(2):152-8. PubMed ID: 11421111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of smoking and abstention from smoking on fibrinogen synthesis in humans.
    Hunter KA; Garlick PJ; Broom I; Anderson SE; McNurlan MA
    Clin Sci (Lond); 2001 Apr; 100(4):459-65. PubMed ID: 11256988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin Turnover in Peritoneal and Hemodialysis.
    Rippe B; Öberg CM
    Semin Dial; 2016 Nov; 29(6):458-462. PubMed ID: 27525385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid.
    Yang SY; Huang JW; Shih KY; Hsu SP; Chu PL; Chu TS; Wu KD
    Nephrol Dial Transplant; 2005 Jan; 20(1):161-6. PubMed ID: 15572386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of hypoalbuminemia in peritoneal dialysis patients: Impact of gender.
    Sikorska D; Olewicz-Gawlik A; Baum E; Pawlaczyk K; Oko A
    Adv Clin Exp Med; 2019 Jun; 28(6):729-735. PubMed ID: 30106520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patients.
    Giordano M; De Feo P; Lucidi P; DePascale E; Giordano G; Cirillo D; Dardo G; Signorelli SS; Castellino P
    Kidney Int; 2001 Jul; 60(1):235-42. PubMed ID: 11422756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease.
    Kaysen GA; Don BR
    Kidney Int Suppl; 2003 May; (84):S94-7. PubMed ID: 12694319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A broad-based metabolic approach to study VLDL apoB100 metabolism in patients with ESRD and patients treated with peritoneal dialysis.
    Prinsen BH; Rabelink TJ; Romijn JA; Bisschop PH; de Barse MM; de Boer J; van Haeften TW; Barrett PH; Berger R; de Sain-van der Velden MG
    Kidney Int; 2004 Mar; 65(3):1064-75. PubMed ID: 14871427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological basis of hypoalbuminemia in ESRD.
    Kaysen GA
    J Am Soc Nephrol; 1998 Dec; 9(12):2368-76. PubMed ID: 9848794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma lipoprotein(a) levels and hypoalbuminemia in peritoneal dialysis patients.
    Ross EA; Shah GM; Kashyap ML
    Int J Artif Organs; 1995 Dec; 18(12):751-6. PubMed ID: 8964640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.